CytoReason vs Pyxis Diagnostics
CytoReason vs Pyxis Diagnostics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Pyxis Diagnostics on 51/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 51/100
- domain rating: 40/100 against 3/100
- headcount: 116 against 3
- headcount growth: +13.7% against -39.5%
- funding raised: $128M against $10.0M
- LinkedIn following: 12,830 against 398
Pyxis Diagnostics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CytoReason | Pyxis Diagnostics |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Developing novel diagnostics to predict patient response to immunotherapy. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Immunotherapy, Oncology, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2017 |
| Headquarters | Tel Aviv, Israel | San Diego, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Pyxis Diagnostics |
|---|---|---|
| Employees | 116 | 3 |
| Headcount growthLast 12 months | +13.7% | -39.5% |
| Total funding | $128M | $10.0M |
| Latest round | Series B | Seed |
| LinkedIn followers | 12,830 | 398 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Pyxis Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 51/100 |
| Traction | 60/100 | 41/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 30/100 | 26/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 3/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Pyxis Diagnostics |
|---|---|---|
| CMS | Not detected | Wix |
| Frameworks | Not detected | Jquery |
| Analytics | Segment | Not detected |
CytoReason vs Pyxis Diagnostics: common questions
Which is better, CytoReason or Pyxis Diagnostics?
On our 0-100 score CytoReason rates higher (68/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do CytoReason and Pyxis Diagnostics compare on the numbers?
CytoReason leads on our overall score (68/100 against 51/100), domain rating (40/100 against 3/100), headcount (116 against 3), headcount growth (+13.7% against -39.5%), funding raised ($128M against $10.0M), LinkedIn following (12,830 against 398).
Read the full CytoReason review and pricing or the Pyxis Diagnostics review and pricing. You can also browse other CytoReason alternatives we track.